Stealth Biotech start-up
Envision a world where every human disease is treatable.
This is our mission.
With many of today's therapeutic milestones being inspired by plant-pathogen interactions, an innovative start-up has emerged to harness TSL's world-class research and pioneer transformative advances in human health.
This stealth biotech start-up taps into unconventional approaches, such as ubiquitin-independent protein degradation, to confront some of the toughest medical challenges.
Supported by TSL Ventures
Contact Roberto Hofmann for more information